Skip to main content
Literatur
1.
Zurück zum Zitat Watabe T, Hosono M, Kinuya S, Yamada T, Yanagida S, Namba M, et al. Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition). Ann Nucl Med. 2021;35:753–66.CrossRef Watabe T, Hosono M, Kinuya S, Yamada T, Yanagida S, Namba M, et al. Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition). Ann Nucl Med. 2021;35:753–66.CrossRef
2.
Zurück zum Zitat Watabe T, Kaneda-Nakashima K, Liu Y, Shirakami Y, Ooe K, Toyoshima A, et al. Enhancement of 211At uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha-therapy of thyroid cancer. J Nucl Med. 2019;60:1301–7.CrossRef Watabe T, Kaneda-Nakashima K, Liu Y, Shirakami Y, Ooe K, Toyoshima A, et al. Enhancement of 211At uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha-therapy of thyroid cancer. J Nucl Med. 2019;60:1301–7.CrossRef
3.
Zurück zum Zitat Lindencrona U, Sillfors-Elverby L, Nilsson M, Forssell-Aronsson E. Adsorption and volatility of free 211At and 125I. Appl Radiat Isot. 2005;62:395–403.CrossRef Lindencrona U, Sillfors-Elverby L, Nilsson M, Forssell-Aronsson E. Adsorption and volatility of free 211At and 125I. Appl Radiat Isot. 2005;62:395–403.CrossRef
4.
Zurück zum Zitat Ohnuki K, Yoshimoto M, Haba H, Manabe S, Takashima H, Yasunaga M, et al. Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide. EJNMMI Phys. 2022;9:39.CrossRef Ohnuki K, Yoshimoto M, Haba H, Manabe S, Takashima H, Yasunaga M, et al. Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide. EJNMMI Phys. 2022;9:39.CrossRef
5.
Zurück zum Zitat Ohnuki K, Yoshimoto M, Fujii H. Radiological protection and biological COVID-19 protection in the nuclear medicine department. Eur J Nucl Med Mol Imaging. 2021;48:6–8.CrossRef Ohnuki K, Yoshimoto M, Fujii H. Radiological protection and biological COVID-19 protection in the nuclear medicine department. Eur J Nucl Med Mol Imaging. 2021;48:6–8.CrossRef
Metadaten
Titel
The safe handling of 211At compounds
verfasst von
Kazunobu Ohnuki
Yasumasa Takenaka
Mitsuyoshi Yoshimoto
Hirofumi Fujii
Publikationsdatum
27.07.2022
Verlag
Springer Nature Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 9/2022
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-022-01778-w

Weitere Artikel der Ausgabe 9/2022

Annals of Nuclear Medicine 9/2022 Zur Ausgabe